The use of convalescent plasma

/in /by

The FDA has published Guidance for Industry (GFI) for the Investigational Use of Convalescent Plasma to support COVID-19-infected patients.

1. What are possible pathways for the use of convalescent plasma to support COVID-19-infected patients?

2. Based on previous uses and current publications on this subject, do you think this is an effective therapy for these patients? Please state your answer and use references to support your statement.

3.  Is there any indication that SARS-CoV-2, the virus that causes COVID-19, can be transmitted by blood components?  Please state your answer and use references to support your statement.

4. What qualifications should donors of convalescent plasma have in order to increase the chances that their donation may help an infected patient?

5. Are there any indications that convalescent plasma may be used to prevent COVID-19 infection?  Please state your answer and use references to support your statement.